Literature DB >> 3543513

Renal handling of magnesium: drug and hormone interactions.

G A Quamme.   

Abstract

Magnesium is the fourth most abundant cation in the human body and the second most common cation in the intracellular fluid. The abundance and distribution of this divalent cation implies an essential role of magnesium in intracellular metabolism. Although no single homeostatic control has been demonstrated for magnesium, the cellular availability of this cation is closely regulated by the gastrointestinal tract, kidney and bone. The purpose of this review is to survey some of the events involved in renal magnesium handling. The excretory side of magnesium balance involves appropriate changes in renal magnesium handling. Present evidence suggests that the renal handling of magnesium is normally a filtration-reabsorption process. Experimental support for secretion remains unconvincing. Renal magnesium reabsorption has distinctive features when compared with that of sodium and calcium. The concentration of magnesium in the proximal tubule rises 1.5 times greater than the glomerular filtrate. Some 20-30% of the filtered magnesium is reabsorbed in the proximal tubule compared to the fractional absorption of sodium or calcium of 50-60%. Although the fractional reabsorption of magnesium is only half that of sodium, it changes in parallel with that of sodium in response to changes in extracellular fluid volume. The major portion of filtered magnesium (some 65%) is reabsorbed in the loop of Henle, mainly in the thick ascending limb. Recent evidence suggests that magnesium reabsorption in the ascending limb may be voltage-dependent and secondary to active sodium chloride reabsorption. Evidence also suggests an important competition between magnesium and calcium for transport at the basolateral surface of the ascending limb cell. The loop of Henle appears to be the major nephron site where magnesium reabsorption is controlled. The principal factors which alter magnesium reabsorption in the loop include parathyroid hormone, changes in plasma magnesium and calcium concentration and the loop diuretics. About 10% of the filtered magnesium is delivered into the distal nephron where only a small fraction of the filtered magnesium is reabsorbed and the transport capacity is readily exceeded with increased magnesium delivery. A number of drugs have been shown to alter magnesium handling; these include antibiotics such as gentamicin, antineoplastic agents such as cisplatin and immunological suppressive drugs such as cyclosporin. The cellular alterations of these diverse drugs leading to renal magnesium wasting are not well understood.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3543513

Source DB:  PubMed          Journal:  Magnesium        ISSN: 0252-1156


  11 in total

1.  Cytoplasmic and intra-nuclear binding of gentamicin does not require endocytosis.

Authors:  Sigrid E Myrdal; Katherine C Johnson; Peter S Steyger
Journal:  Hear Res       Date:  2005-06       Impact factor: 3.208

Review 2.  Renal toxicity and chemotherapy in children with cancer.

Authors:  Antonio Ruggiero; Pietro Ferrara; Giorgio Attinà; Daniela Rizzo; Riccardo Riccardi
Journal:  Br J Clin Pharmacol       Date:  2017-09-20       Impact factor: 4.335

3.  Hypomagnesaemia and hypocalcaemia in a patient with ovarian carcinoma.

Authors:  G P Leese; R T Jung; M C Browning
Journal:  Postgrad Med J       Date:  1993-07       Impact factor: 2.401

Review 4.  Do diuretics cause magnesium deficiency?

Authors:  D L Davies; R Fraser
Journal:  Br J Clin Pharmacol       Date:  1993-07       Impact factor: 4.335

Review 5.  Assessment of chemotherapy-associated nephrotoxicity in children with cancer.

Authors:  R Skinner; A D Pearson; M G Coulthard; A W Skillen; A W Hodson; M E Goldfinch; I Gibb; A W Craft
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

Review 6.  Intracellular mechanisms of aminoglycoside-induced cytotoxicity.

Authors:  Takatoshi Karasawa; Peter S Steyger
Journal:  Integr Biol (Camb)       Date:  2011-07-29       Impact factor: 2.192

7.  Hypocalcemia secondary to hypomagnesemia in a patient with Crohn's disease.

Authors:  Akane Mukai; Shuji Yamamoto; Kazuyoshi Matsumura
Journal:  Clin J Gastroenterol       Date:  2014-12-05

Review 8.  Molecular determinants of magnesium homeostasis: insights from human disease.

Authors:  R Todd Alexander; Joost G Hoenderop; René J Bindels
Journal:  J Am Soc Nephrol       Date:  2008-06-18       Impact factor: 10.121

9.  Synergistic ototoxicity due to noise exposure and aminoglycoside antibiotics.

Authors:  Hongzhe Li; Peter S Steyger
Journal:  Noise Health       Date:  2009 Jan-Mar       Impact factor: 0.867

10.  Increased expression of renal TRPM6 compensates for Mg(2+) wasting during furosemide treatment.

Authors:  Annelies A van Angelen; AnneMiete W van der Kemp; Joost G Hoenderop; René J Bindels
Journal:  Clin Kidney J       Date:  2012-11-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.